$ABBV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AbbVie Inc.. Get notifications about new insider transactions in AbbVie Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Option Exercise | A | 93.50 | 24,549 | 2,295,332 | 24,549 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 1,899 | 0 | 15,035 | 13.1 K to 15 K (+14.46 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 574 | 0 | 13,136 | 12.6 K to 13.1 K (+4.57 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 1,075 | 0 | 12,562 | 11.5 K to 12.6 K (+9.36 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 2,979 | 0 | 11,487 | 8.5 K to 11.5 K (+35.01 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | A | 93.50 | 229,132 | 21,423,842 | 229,132 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 3,675 | 0 | 523,561 | 527.2 K to 523.6 K (-0.70 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 29,107 | 0 | 527,236 | 498.1 K to 527.2 K (+5.84 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 23,604 | 0 | 498,129 | 474.5 K to 498.1 K (+4.97 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 39,109 | 0 | 474,525 | 435.4 K to 474.5 K (+8.98 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 108,442 | 0 | 435,416 | 327 K to 435.4 K (+33.17 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | A | 93.50 | 114,566 | 10,711,921 | 114,566 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 10,125 | 0 | 200,316 | 190.2 K to 200.3 K (+5.32 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 8,214 | 0 | 190,191 | 182 K to 190.2 K (+4.51 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 14,340 | 0 | 181,977 | 167.6 K to 182 K (+8.55 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 39,760 | 0 | 167,637 | 127.9 K to 167.6 K (+31.09 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Option Exercise | A | 93.50 | 72,013 | 6,733,216 | 72,013 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Grant | A | 0.00 | 5,316 | 0 | 17,504 | 12.2 K to 17.5 K (+43.62 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 93.50 | 96,563 | 9,028,641 | 96,563 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 7,972 | 0 | 104,544 | 96.6 K to 104.5 K (+8.25 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 6,555 | 0 | 96,572 | 90 K to 96.6 K (+7.28 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 11,730 | 0 | 90,017 | 78.3 K to 90 K (+14.98 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 32,524 | 0 | 78,287 | 45.8 K to 78.3 K (+71.07 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Option Exercise | A | 93.50 | 62,193 | 5,815,046 | 62,193 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 2,532 | 0 | 25,120 | 22.6 K to 25.1 K (+11.21 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 1,239 | 0 | 22,588 | 21.3 K to 22.6 K (+5.80 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 2,280 | 0 | 21,349 | 19.1 K to 21.3 K (+11.96 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Grant | A | 0.00 | 6,321 | 0 | 19,069 | 12.7 K to 19.1 K (+49.58 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Option Exercise | A | 93.50 | 106,382 | 9,946,717 | 106,382 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 8,859 | 0 | 27,708 | 18.8 K to 27.7 K (+47.00 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 1,485 | 0 | 18,849 | 17.4 K to 18.8 K (+8.55 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 1,710 | 0 | 17,364 | 15.7 K to 17.4 K (+10.92 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Grant | A | 0.00 | 4,741 | 0 | 15,654 | 10.9 K to 15.7 K (+43.44 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Option Exercise | A | 93.50 | 78,559 | 7,345,267 | 78,559 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,999 | 0 | 34,907 | 29.9 K to 34.9 K (+16.71 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,104 | 0 | 29,908 | 25.8 K to 29.9 K (+15.90 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 6,840 | 0 | 25,804 | 19 K to 25.8 K (+36.07 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 18,964 | 0 | 18,964 | 0 to 19 K |
| Jan 06 2020 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Payment of Exercise | F | 88.54 | 902 | 79,863 | 12,188 | 13.1 K to 12.2 K (-6.89 %) |
| Jan 03 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 77 | 0 | 6,933 | |
| Jan 03 2020 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 367 | 0 | 24,692 | |
| Jan 03 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 384 | 0 | 16,872 | |
| Dec 13 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 4,000 | 0 | 326,974 | 331 K to 327 K (-1.21 %) |
| Dec 13 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 4,000 | 0 | 326,974 | 331 K to 327 K (-1.21 %) |
| Dec 12 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 86.44 | 1,713 | 148,072 | 63,591 | 65.3 K to 63.6 K (-2.62 %) |
| Nov 08 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Gift | G | 0.00 | 358 | 0 | 164,480 | 164.8 K to 164.5 K (-0.22 %) |
| Oct 01 2019 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 449 | 0 | 16,291 | |
| Oct 01 2019 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Sell | S | 75.02 | 15,515 | 1,163,873 | 0 | 15.5 K to 0 (-100.00 %) |
| Oct 01 2019 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 429 | 0 | 24,035 | |
| Oct 01 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 6,773 | |
| Sep 18 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Buy | P | 70.42 | 25,000 | 1,760,523 | 164,838 | 139.8 K to 164.8 K (+17.88 %) |
| Sep 11 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 15,010 | 0 | 335,155 | 350.2 K to 335.2 K (-4.29 %) |
| Aug 30 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 3,050 | 0 | 350,165 | 353.2 K to 350.2 K (-0.86 %) |
| Aug 30 2019 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Buy | P | 66.19 | 7,525 | 498,057 | 13,090 | 5.6 K to 13.1 K (+135.22 %) |
| Aug 20 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Buy | P | 64.44 | 15,552 | 1,002,169 | 65,304 | 49.8 K to 65.3 K (+31.26 %) |
| Aug 16 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Aug 16 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 30,000 | 0 | 45,763 | 75.8 K to 45.8 K (-39.60 %) |
| Aug 02 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 15,333 | 0 | 353,215 | 368.5 K to 353.2 K (-4.16 %) |
| Aug 02 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 6,375 | 0 | 368,548 | 374.9 K to 368.5 K (-1.70 %) |
| Aug 02 2019 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Buy | P | 65.66 | 25,000 | 1,641,400 | 117,114 | 92.1 K to 117.1 K (+27.14 %) |
| Aug 02 2019 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Buy | P | 66.02 | 30,000 | 1,980,690 | 92,114 | 62.1 K to 92.1 K (+48.30 %) |
| Jul 31 2019 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Buy | P | 66.35 | 10,000 | 663,500 | 62,114 | 52.1 K to 62.1 K (+19.19 %) |
| Jul 31 2019 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Buy | P | 66.35 | 10,000 | 663,500 | 62,114 | 52.1 K to 62.1 K (+19.19 %) |
| Jul 31 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Buy | P | 67.28 | 30,000 | 2,018,385 | 75,763 | 45.8 K to 75.8 K (+65.56 %) |
| Jul 31 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Buy | P | 67.28 | 30,000 | 2,018,385 | 75,763 | 45.8 K to 75.8 K (+65.56 %) |
| Jul 26 2019 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Payment of Exercise | F | 67.46 | 613 | 41,353 | 8,508 | 9.1 K to 8.5 K (-6.72 %) |
| Jul 02 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 94 | 0 | 6,571 | |
| Jul 02 2019 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 446 | 0 | 23,211 | |
| Jul 02 2019 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 467 | 0 | 15,577 | |
| Jun 28 2019 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 67.30 | 7,500 | 504,750 | 30,662 | 23.2 K to 30.7 K (+32.38 %) |
| Jun 28 2019 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 67.30 | 7,500 | 504,750 | 30,662 | 23.2 K to 30.7 K (+32.38 %) |
| Jun 28 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Buy | P | 67.30 | 30,400 | 2,045,920 | 169,552 | 139.2 K to 169.6 K (+21.85 %) |
| Jun 28 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Buy | P | 67.30 | 30,400 | 2,045,920 | 169,552 | 139.2 K to 169.6 K (+21.85 %) |
| Jun 28 2019 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Buy | P | 67.50 | 11,500 | 776,250 | 52,114 | 40.6 K to 52.1 K (+28.32 %) |
| Jun 28 2019 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Buy | P | 67.50 | 11,500 | 776,250 | 52,114 | 40.6 K to 52.1 K (+28.32 %) |
| May 07 2019 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 2,419 | 0 | 19,548 | 17.1 K to 19.5 K (+14.12 %) |
| May 07 2019 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,419 | 0 | 42,154 | 39.7 K to 42.2 K (+6.09 %) |
| May 07 2019 | ABBV | AbbVie Inc. | Roberts Rebecca B | Director | Grant | A | 0.00 | 2,419 | 0 | 4,318 | 1.9 K to 4.3 K (+127.38 %) |
| May 07 2019 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 2,419 | 0 | 23,162 | 20.7 K to 23.2 K (+11.66 %) |
| May 07 2019 | ABBV | AbbVie Inc. | MEYER MELODY B | Director | Grant | A | 0.00 | 2,419 | 0 | 7,088 | 4.7 K to 7.1 K (+51.81 %) |
| May 07 2019 | ABBV | AbbVie Inc. | Hart Brett J | Director | Grant | A | 0.00 | 2,419 | 0 | 10,062 | 7.6 K to 10.1 K (+31.65 %) |
| May 07 2019 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 2,419 | 0 | 17,548 | 15.1 K to 17.5 K (+15.99 %) |
| May 07 2019 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 2,419 | 0 | 40,614 | 38.2 K to 40.6 K (+6.33 %) |
| May 07 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,419 | 0 | 26,107 | 23.7 K to 26.1 K (+10.21 %) |
| Apr 02 2019 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 421 | 0 | 14,907 | |
| Apr 02 2019 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 403 | 0 | 22,459 | |
| Apr 02 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 85 | 0 | 6,389 | |
| Mar 25 2019 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Sell | S | 79.69 | 475 | 37,853 | 9,121 | 9.6 K to 9.1 K (-4.95 %) |
| Mar 15 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Sell | S | 80.00 | 25,000 | 2,000,000 | 139,838 | 164.8 K to 139.8 K (-15.17 %) |
| Mar 15 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Sell | S | 80.00 | 25,000 | 2,000,000 | 139,838 | 164.8 K to 139.8 K (-15.17 %) |
| Mar 06 2019 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Sell | S | 79.03 | 15,797 | 1,248,480 | 93,312 | 109.1 K to 93.3 K (-14.48 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 79.41 | 6,907 | 548,485 | 49,752 | 56.7 K to 49.8 K (-12.19 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Payment of Exercise | F | 79.41 | 24,275 | 1,927,678 | 164,838 | 189.1 K to 164.8 K (-12.84 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Payment of Exercise | F | 79.41 | 12,569 | 998,104 | 109,109 | 121.7 K to 109.1 K (-10.33 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Payment of Exercise | F | 79.41 | 12,345 | 980,316 | 15,515 | 27.9 K to 15.5 K (-44.31 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | Michael Robert A. | SVP, Chief Financia ... | Payment of Exercise | F | 79.41 | 3,206 | 254,588 | 10,913 | 14.1 K to 10.9 K (-22.71 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 79.41 | 22,956 | 1,822,936 | 45,763 | 68.7 K to 45.8 K (-33.41 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 79.41 | 72,925 | 5,790,974 | 374,923 | 447.8 K to 374.9 K (-16.28 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | A | 79.02 | 179,127 | 14,154,616 | 179,127 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 2,964 | 0 | 447,848 | 450.8 K to 447.8 K (-0.66 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 23,605 | 0 | 450,812 | 427.2 K to 450.8 K (+5.53 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 39,109 | 0 | 427,207 | 388.1 K to 427.2 K (+10.08 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 42,649 | 0 | 388,098 | 345.4 K to 388.1 K (+12.35 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 59,246 | 0 | 345,449 | 286.2 K to 345.4 K (+20.70 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Option Exercise | A | 79.02 | 68,535 | 5,415,636 | 68,535 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Grant | A | 0.00 | 8,481 | 0 | 189,113 | 180.6 K to 189.1 K (+4.70 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Grant | A | 0.00 | 14,989 | 0 | 180,632 | 165.6 K to 180.6 K (+9.05 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Grant | A | 0.00 | 13,110 | 0 | 165,643 | 152.5 K to 165.6 K (+8.59 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Grant | A | 0.00 | 18,211 | 0 | 152,533 | 134.3 K to 152.5 K (+13.56 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Option Exercise | A | 79.02 | 60,747 | 4,800,228 | 60,747 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 8,481 | 0 | 166,428 | 157.9 K to 166.4 K (+5.37 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 14,989 | 0 | 157,947 | 143 K to 157.9 K (+10.48 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 15,945 | 0 | 142,958 | 127 K to 143 K (+12.55 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 22,150 | 0 | 127,013 | 104.9 K to 127 K (+21.12 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Option Exercise | A | 79.02 | 64,485 | 5,095,605 | 64,485 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Grant | A | 0.00 | 8,565 | 0 | 142,567 | 134 K to 142.6 K (+6.39 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Grant | A | 0.00 | 14,989 | 0 | 134,002 | 119 K to 134 K (+12.59 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Grant | A | 0.00 | 15,375 | 0 | 119,013 | 103.6 K to 119 K (+14.84 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Grant | A | 0.00 | 21,357 | 0 | 103,638 | 82.3 K to 103.6 K (+25.96 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | A | 79.02 | 62,305 | 4,923,341 | 62,305 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 8,215 | 0 | 152,002 | 143.8 K to 152 K (+5.71 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 14,340 | 0 | 143,787 | 129.4 K to 143.8 K (+11.08 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 13,350 | 0 | 129,447 | 116.1 K to 129.4 K (+11.50 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 18,545 | 0 | 116,097 | 97.6 K to 116.1 K (+19.01 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 79.02 | 49,065 | 3,877,116 | 49,065 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 6,555 | 0 | 68,719 | 62.2 K to 68.7 K (+10.54 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 11,730 | 0 | 62,164 | 50.4 K to 62.2 K (+23.26 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 14,035 | 0 | 50,434 | 36.4 K to 50.4 K (+38.56 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 19,495 | 0 | 36,399 | 16.9 K to 36.4 K (+115.33 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Option Exercise | A | 79.02 | 30,763 | 2,430,892 | 30,763 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,105 | 0 | 27,860 | 23.8 K to 27.9 K (+17.28 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 6,840 | 0 | 23,755 | 16.9 K to 23.8 K (+40.44 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 7,080 | 0 | 16,915 | 9.8 K to 16.9 K (+71.99 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Grant | A | 0.00 | 9,835 | 0 | 9,835 | 0 to 9.8 K |
| Feb 22 2019 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Option Exercise | A | 79.02 | 34,267 | 2,707,778 | 34,267 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Grant | A | 0.00 | 4,281 | 0 | 121,678 | 117.4 K to 121.7 K (+3.65 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Grant | A | 0.00 | 7,170 | 0 | 117,397 | 110.2 K to 117.4 K (+6.50 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Grant | A | 0.00 | 7,080 | 0 | 110,227 | 103.1 K to 110.2 K (+6.86 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Grant | A | 0.00 | 9,835 | 0 | 103,147 | 93.3 K to 103.1 K (+10.54 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Michael Robert A. | SVP, Chief Financia ... | Option Exercise | A | 79.02 | 54,517 | 4,307,933 | 54,517 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | Michael Robert A. | SVP, Chief Financia ... | Grant | A | 0.00 | 1,485 | 0 | 14,119 | 12.6 K to 14.1 K (+11.75 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Michael Robert A. | SVP, Chief Financia ... | Grant | A | 0.00 | 1,710 | 0 | 12,634 | 10.9 K to 12.6 K (+15.65 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Michael Robert A. | SVP, Chief Financia ... | Grant | A | 0.00 | 1,695 | 0 | 10,924 | 9.2 K to 10.9 K (+18.37 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Michael Robert A. | SVP, Chief Financia ... | Grant | A | 0.00 | 2,353 | 0 | 9,229 | 6.9 K to 9.2 K (+34.22 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Option Exercise | A | 79.02 | 25,700 | 2,030,814 | 25,700 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 2,970 | 0 | 56,659 | 53.7 K to 56.7 K (+5.53 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 3,909 | 0 | 53,689 | 49.8 K to 53.7 K (+7.85 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 3,645 | 0 | 49,780 | 46.1 K to 49.8 K (+7.90 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 5,062 | 0 | 46,135 | 41.1 K to 46.1 K (+12.32 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Option Exercise | A | 79.02 | 32,710 | 2,584,744 | 32,710 |